Clarity Pointe announces groundbreaking of new memory care community in Tallahassee

Clarity Pointe is excited to announce the groundbreaking of its newest memory care community, Clarity Pointe Tallahassee.

from Dementia Big http://ift.tt/2hyzzhF via alcoholic dementia

http://ift.tt/2hEsGAb

Clarity Pointe announces groundbreaking of new memory care community in Tallahassee

Clarity Pointe announces groundbreaking of new memory care community in Tallahassee:

Dementia Big
Clarity Pointe is excited to announce the groundbreaking of its newest memory care community, Clarity Pointe Tallahassee.

http://ift.tt/2iAftW0

Pot may restrict blood flow to brain: study

Pot may restrict blood flow to brain: study:

Dementia Big
(HealthDay)—Marijuana appears to hamper blood flow to the brain, which theoretically could affect your memory and ability to reason, a new study suggests.

http://ift.tt/2iN28Jq

Pot may restrict blood flow to brain: study

(HealthDay)—Marijuana appears to hamper blood flow to the brain, which theoretically could affect your memory and ability to reason, a new study suggests.

from Dementia Big http://ift.tt/2ixr4F9 via alcoholic dementia

http://ift.tt/2ilJrNT

Two research studies on new molecules could potentially treat Alzheimer's disease

Two research studies on new molecules could potentially treat Alzheimer's disease:

Dementia Big
This year, results have been published of two significant research studies about molecules that could potentially treat Alzheimer’s disease.

http://ift.tt/2hSVrFz

Two research studies on new molecules could potentially treat Alzheimer's disease

This year, results have been published of two significant research studies about molecules that could potentially treat Alzheimer’s disease.

from Dementia Big http://ift.tt/2hB8Plo via alcoholic dementia

http://ift.tt/2hBcYGi

Investigation into new molecules for potential Alzheimer's treatment

Investigation into new molecules for potential Alzheimer's treatment:

Dementia Big
Two significant research studies have been published in Molecular Pharmaceutics and Current Alzheimer Research regarding molecules that could potentially treat Alzheimer’s disease. The chief researcher in both studies was Yan Ivanenkov, the head of the Laboratory of Medical Chemistry and Bioinformatics at MIPT. Mark Veselov, another MIPT employee, also participated in the second study.

http://ift.tt/2hz4H5t